Prime Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-219.25	-198.13	-121.82	-165.37	-3.41	-7.59
Depreciation & Amortization	5.66	4.65	2.22	0.57	0.04	-
Loss (Gain) From Sale of Assets	0.03	0.03	0.01	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	12.02	-	0.58
Loss (Gain) From Sale of Investments	-4.13	-1.03	7.88	1.11	-10.87	-
Stock-Based Compensation	24.56	13.91	6.46	1.75	0.39	0.47
Other Operating Activities	13.5	12.51	8.83	84.67	8.14	1.06
Change in Accounts Payable	-5.44	9.14	2.46	1.19	0.25	-
Change in Other Net Operating Assets	-69.82	-6.49	-37.86	29.99	-0.09	1.48
Operating Cash Flow	-182.97	-165.41	-131.83	-34.08	-5.54	-4
Capital Expenditures	-7.34	-8.72	-16.1	-4.15	-0.64	-
Investment in Securities	68.11	27.61	-30.34	-68.98	-	-
Other Investing Activities	0.72	-0.17	-0.67	-0.5	-0.42	-
Investing Cash Flow	61.49	18.71	-47.1	-73.63	-1.06	-
Issuance of Common Stock	171.27	0.66	185.54	-	-	0
Other Financing Activities	24.8	-	-4.04	-1.09	-0.02	-
Financing Cash Flow	196.07	0.66	181.49	269.28	34.93	29.94
Net Cash Flow	74.58	-146.05	2.57	161.57	28.33	25.94
Free Cash Flow	-190.32	-174.14	-147.92	-38.23	-6.18	-4
Free Cash Flow Margin	-23789.63%	-	-	-	-118.68%	-
Free Cash Flow Per Share	-1.75	-1.91	-4.36	-2.95	-2.34	-2.69
Levered Free Cash Flow	-156.42	-96.21	-117.62	-6.8	-6.19	-
Unlevered Free Cash Flow	-156.21	-96.21	-117.62	-6.8	-6.19	-
Change in Net Working Capital	46.08	-13.51	37.37	-47.84	5.41	-

Source: S&P Capital IQ. Standard template. Financial Sources.